Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
Klus Pharma Inc.
Klus Pharma Inc.
University of Texas Southwestern Medical Center
Ohio State University Comprehensive Cancer Center
Stanford University
Fuda Cancer Hospital, Guangzhou
National Institutes of Health Clinical Center (CC)
GERCOR - Multidisciplinary Oncology Cooperative Group
National Cancer Institute (NCI)